Check out this conversation with Dr. Bote Bruinsma, Senior Medical Director, Clinical Development at Vertex Pharmaceuticals, to learn about Vertex’s clinical trial investigating islet cell replacement therapy for adults with type 1 diabetes and recurrent severe hypoglycemic events.